Literature DB >> 18407646

Phorbasins D-F: diterpenyl-taurines from a southern Australian marine sponge, Phorbas sp.

Hua Zhang1, Robert J Capon.   

Abstract

Fractionation of an Australian marine sponge, Phorbas sp., yielded the known phorbasins B (1) and C (2) together with three novel diterpenyl-taurines, phorbasins D-F (3-5). Partial absolute structures were assigned on the basis of detailed spectroscopic analysis. Phorbasins D-F (3-5) are the first reported examples of terpenyl-taurines linked via an amine moiety, and phorbasins E and F (4 and 5) incorporate an unprecedented heterocycle. A plausible biosynthetic route is proposed for the incorporation of taurine and heterocycle formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407646     DOI: 10.1021/ol8004744

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Metallacycle-Mediated Cross-Coupling in Natural Product Synthesis.

Authors:  Natasha F O'Rourke; Matthew J Kier; Glenn C Micalizio
Journal:  Tetrahedron       Date:  2016-09-07       Impact factor: 2.457

Review 2.  Bioactive natural products from marine sponges belonging to family Hymedesmiidae.

Authors:  Asmaa Abo Elgoud Said; Basma Khalaf Mahmoud; Eman Zekry Attia; Usama Ramadan Abdelmohsen; Mostafa Ahmed Fouad
Journal:  RSC Adv       Date:  2021-04-30       Impact factor: 3.361

3.  Phorbaketal A, Isolated from the Marine Sponge Phorbas sp., Exerts Its Anti-Inflammatory Effects via NF-κB Inhibition and Heme Oxygenase-1 Activation in Lipopolysaccharide-Stimulated Macrophages.

Authors:  Yun-Ji Seo; Kyung-Tae Lee; Jung-Rae Rho; Jung-Hye Choi
Journal:  Mar Drugs       Date:  2015-11-19       Impact factor: 5.118

Review 4.  Exploring Chemical Diversity of Phorbas Sponges as a Source of Novel Lead Compounds in Drug Discovery.

Authors:  Alessia Caso; Fernanda Barbosa da Silva; Germana Esposito; Roberta Teta; Gerardo Della Sala; Laura P A Nunes Cavalcanti; Alessandra Leda Valverde; Roberto Carlos C Martins; Valeria Costantino
Journal:  Mar Drugs       Date:  2021-11-26       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.